Medical Specialty >> Oncology
High-Nicotine E-Cigs May Be Gateway to Smoking for Teens
12:00 PM CDT.
Many more 10th graders who tried the devices were hooked on 'regular' cigarettes later, study found
Read article
- Tighter Rules on Arsenic in Water Saved Lives: Study
- Medical Marijuana Won’t Help Most Sick Kids
- Textured Breast Implants Linked to Rare Cancer
- How Many Mutant Genes Drive Cancer?
JOURNAL UPDATE
2003 to 2014 Saw Drop in Urinary Arsenic in Public Water Users
12:00 PM CDT. Reduction occurred after implementation of EPA's maximum contaminant level for arsenic- Limited Evidence of Benefit for Medical Cannabinoids in Children
- Leukemia Patients Who Survive Severe GVHD Often Fare Worse
- Clinician Job Satisfaction Linked to Improved Burnout Scores
MONTHLY JOURNAL SUMMARY
September 2017 Briefing - Hematology & Oncology
September 30, 2017. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Characterization of patients with ovarian carcinoma who respond to the PARP inhibitor rucaparib
Elizabeth M. Swisher, MD.
Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity…
Bert Vogelstein explains cancer and the unavoidable replicative mutations
Bert Vogelstein, MD.
Investigators at Johns Hopkins University in Baltimore used complex mathematical modeling to track mutations driving abnormal cell growth for 32 types of cancer. From their calculations, the researchers believe that the bulk of cancers are caused by random DNA copying errors (replicative mutations).…
MEDICAL FOCUS
BRCA mutation testing
By Tamer M. Fouad, M.D.The BRCA gene test is used to identify mutations in either one of the two breast cancer susceptibility genes, BRCA1 and BRCA2. Women who have inherited…
DISCUSSION
RE: Aspirin Use as Treatment in Colorectal Cancer: Teaching an Old Dog New Tricks
By Jeffrey A. Gordon, M.D.Thank you for reading my article. Interesting theory. Lots of research is ongoing to figure out the many ways aspirin does it magic.
